The use of the EEG in measuring therapeutic drug action: Focus on depression and antidepressants

Journal of Psychopharmacology

Volumn 25, Issue 9, 2011, Pages 1175-1191

  Alhaj, Hamid ^a,b   Wisniewski, Grzegorz ^c   McAllister Williams, R Hamish ^a,b  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

^c Clare Mental Health Services   (Ireland)

Author keywords

Antidepressants; depression; EEG; ERP; HPA axis

Indexed keywords

ANTIDEPRESSANT AGENT; BUSPIRONE; CITALOPRAM; CLOMIPRAMINE; FLUOXETINE; HYDROCORTISONE; IMIPRAMINE; MAPROTILINE; PLACEBO; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ACTION POTENTIAL; BRAIN FUNCTION; COGNITION; CORTICAL SYNCHRONIZATION; DEPRESSION; DRUG ACTIVITY; DRUG EFFICACY; ELECTROENCEPHALOGRAPHY; EPISODIC MEMORY; EVENT RELATED POTENTIAL; EVOKED AUDITORY RESPONSE; FOURIER TRANSFORMATION; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HEMODYNAMICS; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INDEPENDENT COMPONENT ANALYSIS; MAGNETOENCEPHALOGRAPHY; MEMORY CONSOLIDATION; NEUROBIOLOGY; NEUROIMAGING; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; POSTSYNAPTIC POTENTIAL; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; REVIEW; SENSITIVITY AND SPECIFICITY; SINGLE DRUG DOSE; SYNAPSE; TEMPORAL LOBE EPILEPSY; TRANSCRANIAL MAGNETIC STIMULATION;

ANIMALS; ANTIDEPRESSIVE AGENTS; CLINICAL TRIALS AS TOPIC; DEPRESSION; DRUG DESIGN; ELECTROENCEPHALOGRAPHY; HUMANS; MOOD DISORDERS; OUTCOME ASSESSMENT (HEALTH CARE);

EID: 80054016771     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881110388323     Document Type: Review

References (191)

1. Alhaj HA, Massey AE, McAllister-Williams RH. A study of the neural correlates of episodic memory and HPA axis status in drug-free depressed patients and healthy controls. J Psychiatr Res. 2007 ; 41 (3-4). 295-304 (Pubitemid 44873016)
2. Alhaj HA, Massey AE, McAllister-Williams RH. Effects of cortisol on the laterality of the neural correlates of episodic memory. J Psychiatr Res. 2008 ; 42 (12). 971-981
3. Allen J, Urry H, Hitt S, Coan J. The stability of resting frontal electroencephalographic asymmetry in depression. Psychophysiology. 2004 ; 41 (2). 269-280 (Pubitemid 38524099)
4. Altshuler LL, Devinsky O, Post RM, Theodore W. Depression, anxiety, and temporal lobe epilepsy. Laterality of focus and symptoms. Arch Neurol. 1990 ; 47 (3). 284-288
5. Ancy J, Gangadhar BN, Janakiramaiah N. 'Normal' P300 amplitude predicts rapid response to ECT in melancholia. J Affect Disord. 1996 ; 41 (3). 211-215 (Pubitemid 26422951)
6. Anderer P, Saletu B, Pascual-Marqui RD. Effect of the 5-HT(1A) partial agonist buspirone on regional brain electrical activity in man: a functional neuroimaging study using low-resolution electromagnetic tomography (LORETA). Psychiatry Res. 2000 ; 100 (2). 81-96
7. Baillet S, Riera JJ, Marin G, Mangin JF, Aubert J, Garnero L. Evaluation of inverse methods and head models for EEG source localization using a human skull phantom. Phys Med Biol. 2001 ; 46 (1). 77-96 (Pubitemid 32104872)
8. Barbanoj MJ, Anderer P, Antonijoan RM, Torrent J, Saletu B, Jane F. Topographical pharmaco-EEG mapping of increasing doses of buspirone and its comparison with diazepam. Human Psychopharm. 1994 ; 9: 101-109 (Pubitemid 24133932)
9. Bares M, Brunovsky M, Kopecek M, et al. Changes in QEEG prefrontal cordance as a predictor of response to antidepressants in patients with treatment resistant depressive disorder: a pilot study. J Psychiatr Res. 2007 ; 41 (3-4). 319-325 (Pubitemid 44854994)
10. Bares M, Brunovsky M, Kopecek M, et al. (2008) Early reduction in prefrontal theta QEEG cordance value predicts response to venlafaxine treatment in patients with resistant depressive disorder. Eur Psychiatry 23(5): 350-355.
11. Bares M, Brunovsky M, Novak T, et al. (2010) The change of prefrontal QEEG theta cordance as a predictor of response to bupropion treatment in patients who had failed to respond to previous antidepressant treatments. Eur Neuropsychopharmacol 20(7): 459-466.
12. Bel N, Artigas F. Fluvoxamine preferentially increases extracellular 5-hydroxytryptamine in the raphe nuclei: an in vivo microdialysis study. Eur J Pharmacol. 1992 ; 229 (1). 101-103
13. Bermpohl F, Fregni F, Boggio PS, et al. Effect of low-frequency transcranial magnetic stimulation on an affective go/no-go task in patients with major depression: role of stimulation site and depression severity. Psychiatry Res. 2006 ; 141 (1). 1-13 (Pubitemid 43011346)
14. Bismark AW, Moreno FA, Stewart JL, et al. Polymorphisms of the HTR1a allele are linked to frontal brain electrical asymmetry. Biol Psychol. 2010 ; 83 (2). 153-158
15. Blackwood DH, Sharp CW, Walker MT, Doody GA, Glabus MF, Muir WJ. Implications of comorbidity for genetic studies of bipolar disorder: P300 and eye tracking as biological markers for illness. Brit J Psychiatry. 1996 ; 168 (Suppl. 30). 85-92 (Pubitemid 26000491)
16. Blier P, de Montigny C. Current advances in the treatment of depression. Trends Pharmacol. 1994 ; 15: 220-226
17. Bochkarev VK, Avedisova AS, Liupaeva NV. Placebo to antidepressant effects ratio by electroencephalographic data. Zhurnal Nevrologii i Psikhiatrii Imeni S S Korsakova. 2004 ; 104 (11). 42-48
18. Bogdanov NN, Bogdanov MB. The role of 5-HT1A serotonin and D2 dopamine receptors in buspirone effects on cortical electrical activity in rats. Neurosci Lett. 1994 ; 177 (1-2). 1-4
19. Brody AL, Saxena S, Silverman DH, et al. Brain metabolic changes in major depressive disorder from pre- to post-treatment with paroxetine. Psychiatry Res. 1999 ; 91 (3). 127-139 (Pubitemid 29474048)
20. Bruder GE, Tenke CE, Warner V, et al. Electroencephalographic measures of regional hemispheric activity in offspring at risk for depressive disorders. Biol Psychiatry. 2005 ; 57 (4). 328-335 (Pubitemid 40215761)
21. Bruder GE, Sedoruk JP, Stewart JW, McGrath PJ, Quitkin FM, Tenke CE. Electroencephalographic alpha measures predict therapeutic response to a selective serotonin reuptake inhibitor antidepressant: pre- and post-treatment findings. Biol Psychiatry. 2008 ; 63 (12). 1171-1177 (Pubitemid 351734498)
22. Bruder GE, Stewart JW, Tenke CE, et al. Electroencephalographic and perceptual asymmetry differences between responders and nonresponders to an SSRI antidepressant. Biol Psychiatry. 2001 ; 49 (5). 416-425 (Pubitemid 32234304)
23. Bruder GE, Towey JP, Stewart JW, Friedman D, Tenke C, Quitkin FM. Event-related potentials in depression: influence of task, stimulus hemifield and clinical features on P3 latency. Biol Psychiatry. 1991 ; 30 (3). 233-246
24. Bruder G, Fong R, Tenke CE, et al. Regional brain asymmetries in major depression with or without an anxiety disorder: a quantitative electroencephalographic study. Biol Psychiatry. 1997 ; 41 (9). 939-948 (Pubitemid 27213704)
25. Buchsbaum MS, Wu J, Siegel BV, et al. Effect of sertraline on regional metabolic rate in patients with affective disorder. Biol Psychiatry. 1997 ; 41 (1). 15-22 (Pubitemid 27050641)
26. Burt T, Lisanby SH, Sackeim HA. Neuropsychiatric applications of transcranial magnetic stimulation: a meta analysis. Int J Neuropsychopharmacol. 2002 ; 5 (1). 73-103 (Pubitemid 34241070)
27. Carozzo S, Fornaro S, Garbarino S, Saturno M, Sannita WG. From neuroscience to application in neuropharmacology: a generation of progress in electrophysiology. Clin EEG Neurosci. 2006 ; 37 (2). 121-134 (Pubitemid 43726203)
28. Carroll BJ, Curtis GC, Mendels J. Cerebrospinal fluid and plasma free cortisol concentrations in depression. Psychol Med. 1976 ; 6 (2). 235-244
29. Chapotot F, Buguet A, Gronfier C, Brandenberger G. Hypothalamo-pituitary- adrenal axis activity is related to the level of central arousal: effect of sleep deprivation on the association of high-frequency waking electroencephalogram with cortisol release. Neuroendocrin. 2001 ; 73 (5). 312-321 (Pubitemid 32588855)
30. Clifford EM, Gartside SE, Umbers V, Cowen PJ, Hajos M, Sharp T. Electrophysiological and neurochemical evidence that pindolol has agonist properties at the 5-HT(1A) autoreceptor in vivo. Brit J Pharmacol. 1998 ; 124 (1). 206-212 (Pubitemid 28210061)
31. Coan JA, Allen JJB The Asymmetrical Brain. Hugdahl K Davidson RJ, ed. Cambridge, MA: MIT Press ; 2003: 565-615.
32. Coan J, Allen J. Frontal EEG asymmetry as a moderator and mediator of emotion. Biol Psychol. 2004 ; 67 (1-2). 7-50
33. Coburn KL, Lauterbach EC, Boutros NN, Black KJ, Arciniegas DB, Coffey CE. The value of quantitative electroencephalography in clinical psychiatry: a report by the Committee on Research of the American Neuropsychiatric Association. J Neuropsychiatry Clin Neurosci. 2006 ; 18 (4). 460-500 (Pubitemid 44717482)
34. Compton RJ, Banich MT, Mohanty A, et al. Paying attention to emotion: an fMRI investigation of cognitive and emotional stroop tasks. Cogn Affect Behav Neurosci. 2003 ; 3 (2). 81-96 (Pubitemid 37517025)
35. Cook IA, Leuchter AF, Morgan M, et al. Early changes in prefrontal activity characterize clinical responders to antidepressants. Neuropsychopharmacology. 2002 ; 27 (1). 120-131 (Pubitemid 34626748)
36. Cook IA, Leuchter AF, Morgan ML, Stubbeman W, Siegman B, Abrams M. Changes in prefrontal activity characterize clinical response in SSRI nonresponders: a pilot study. J Psychiatr Res. 2005 ; 39 (5). 461-466 (Pubitemid 40909989)
37. Davidson RJ. Anterior electrophysiological asymmetries, emotion, and depression: conceptual and methodological conundrums. Psychophysiology. 1998 ; 35 (5). 607-614 (Pubitemid 28376067)
38. Davidson RJ, Henriques J The Neuropsychology of Emotion. Borod JC, ed. New York: Oxford University Press ; 2000: 269-297.
39. Davidson RJ, Irwin W, Anderle MJ, Kalin NH. The neural substrates of affective processing in depressed patients treated with venlafaxine. Am J Psychiatry. 2003 ; 160 (1). 64-75 (Pubitemid 36042428)
40. Debener S, Beauducel A, Nessler D, Brocke B, Heilemann H, Kayser J. Is resting anterior EEG alpha asymmetry a trait marker for depression? Findings for healthy adults and clinically depressed patients. Neuropsychobiology. 2000 ; 41 (1). 31-37 (Pubitemid 30025909)
41. Debener S, Strobel A, Kurschner K, et al. Is auditory evoked potential augmenting/reducing affected by acute tryptophan depletion?. Biol Psychol. 2002 ; 59 (2). 121-133 (Pubitemid 34242636)
42. de Visser SJ, van der Post JP, de Waal PP, Cornet F, Cohen AF, van Gerven JM. Biomarkers for the effects of benzodiazepines in healthy volunteers. Br J Clin Pharmacol. 2003 ; 55 (1). 39-50 (Pubitemid 36110838)
43. Dierks T, Barta S, Demisch L, et al. Intensity dependence of auditory evoked potentials (AEPs) as biological marker for cerebral serotonin levels: effects of tryptophan depletion in healthy subjects. Psychopharmacology. 1999 ; 146 (1). 101-107 (Pubitemid 29441120)
44. Dimpfel W. Pharmacological modulation of dopaminergic brain activity and its reflection in spectral frequencies of the rat electropharmacogram. Neuropsychobiology. 2008 ; 58 (3-4). 178-186
45. Dougherty DD, Rauch SL. Brain correlates of antidepressant treatment outcome from neuroimaging studies in depression. Psychiatr Clin North Am. 2007 ; 30 (1). 91-103 (Pubitemid 46386304)
46. Drevets WC, Raichle ME The Cognitive Neurosciences. Gazzaniga MS, ed. Cambridge, MA: MIT Press ; 1995: 1153-1164.
47. Ebert D, Feistel H, Barocka A, Kaschka W. Increased limbic blood flow and total sleep deprivation in major depression with melancholia. Psychiatry Res. 1994 ; 55 (2). 101-109 (Pubitemid 24197577)
48. Engels AS, Heller W, Mohanty A, et al. Specificity of regional brain activity in anxiety types during emotion processing. Psychophysiology. 2007 ; 44 (3). 352-363 (Pubitemid 46587649)
49. Evans KC, Dougherty DD, Pollack MH, Rauch SL. Using neuroimaging to predict treatment response in mood and anxiety disorders. Ann Clin Psychiatry. 2006 ; 18 (1). 33-42
50. Fawcett J, Barkin RL. Efficacy issues with antidepressants. J Clin Psychiatry. 1997 ; 58 (Suppl. 6). 32-39 (Pubitemid 27310167)
51. Fell J, Klaver P, Elger CE, Fernandez G. Suppression of EEG gamma activity may cause the attentional blink. Conscious Cogn. 2002 ; 11 (1). 114-122 (Pubitemid 34211891)
52. Frodl T, Bokde AL, Scheuerecker J, et al. Functional connectivity bias of the orbitofrontal cortex in drug-free patients with major depression. Biol Psychiatry. 2010 ; 67 (2). 161-167
53. Galderisi S, Mucci A, Bucci P, Mignone ML, Maj M. Influence of moclobemide on cognitive functions of nine depressed patients: pilot trial with neurophysiological and neuropsychological indices. Neuropsychobiology. 1996 ; 33 (1). 48-54 (Pubitemid 26026676)
54. Gallinat J, Bottlender R, Juckel G, et al. The loudness dependency of the auditory evoked N1/P2-component as a predictor of the acute SSRI response in depression. Psychopharmacology. 2000 ; 148 (4). 404-411 (Pubitemid 30169759)
55. Gershon AA, Dannon PN, Grunhaus L. Transcranial magnetic stimulation in the treatment of depression. Am J Psychiatry. 2003 ; 160 (5). 835-845 (Pubitemid 41079567)
56. Gibbons JL, McHugh PR. Plasma cortisol in depressive illness. J Psychiatr Res. 1962 ; 1: 162-171
57. Grin-Yatsenko VA, Baas I, Ponomarev VA, Kropotov JD. Independent component approach to the analysis of EEG recordings at early stages of depressive disorders. Clin Neurophysiol. 2010 ; 121 (3). 281-289
58. Gronfier C, Chapotot F, Weibel L, Jouny C, Piquard F, Brandenberger G. Pulsatile cortisol secretion and EEG delta waves are controlled by two independent but synchronized generators. Am J Physiol. 1998 ; 275 (1 Pt 1). E94-100
59. Gruzelier J. A theory of alpha/theta neurofeedback, creative performance enhancement, long distance functional connectivity and psychological integration. Cogn Process. 2009 ; 10 (Suppl. 1). S101-S109
60. Guidi M, Scarpino O, Angeleri F. Topographic EEG and flash visual evoked potentials in elderly subjects, depressed patients, and demented patients. Psychiatry Res. 1989 ; 29 (3). 403-406 (Pubitemid 19265405)
61. Hagemann D. Individual differences in anterior EEG asymmetry: methodological problems and solutions. Biol Psychol. 2004 ; 67 (1-2). 157-182 (Pubitemid 38582078)
62. Handy TC Event-Related Potentials: A Methods Handbook. Cambridge, MA: MIT Press ; 2004 :
63. Hansen ES, Prichep LS, Bolwig TG, John ER. Quantitative electroencephalography in OCD patients treated with paroxetine. Clin Electroencephalogr. 2003 ; 34 (2). 70-74 (Pubitemid 36583134)
64. Hansenne M, Ansseau M. P300 event-related potential and serotonin-1A activity in depression. Eur Psychiatry. 1999 ; 14 (3). 143-147 (Pubitemid 36187795)
65. Harden CL. The co-morbidity of depression and epilepsy: epidemiology, etiology, and treatment. Neurology. 2002 ; 59 (6 Suppl. 4). S48-S55
66. Hegerl U, Juckel G. Intensity dependence of auditory evoked potentials as an indicator of central serotonergic neurotransmission: a new hypothesis. Biol Psychiatry. 1993 ; 33 (3). 173-187 (Pubitemid 23089966)
67. Hegerl U, Gallinat J, Juckel G. Event-related potentials. Do they reflect central serotonergic neurotransmission and do they predict clinical response to serotonin agonists?. J Affect Disord. 2001 ; 62 (1-2). 93-100 (Pubitemid 32126614)
68. Henriques JB, Davidson RJ. Regional brain electrical asymmetries discriminate between previously depressed and healthy control subjects. J Abnorm Psychol. 1990 ; 99 (1). 22-31 (Pubitemid 20117083)
69. Henriques JB, Davidson R. Left frontal hypoactivation in depression. J Abnorm Psychol. 1991 ; 100 (4). 535-545
70. Herrington JD, Heller W, Mohanty A, et al. Localization of asymmetric brain function in emotion and depression. Psychophysiology. 2010 ; 47 (3). 442-454
71. Herrmann CS, Frund I, Lenz D. Human gamma-band activity: a review on cognitive and behavioral correlates and network models. Neurosci Biobehav Rev. 2010 ; 34 (7). 981-992
72. Hesdorffer DC, Hauser WA, Annegers JF, Cascino G. Major depression is a risk factor for seizures in older adults. Ann Neurol. 2000 ; 47 (2). 246-249 (Pubitemid 30078574)
73. Hetzel G, Moeller O, Evers S, et al. The astroglial protein S100B and visually evoked event-related potentials before and after antidepressant treatment. Psychopharmacology. 2005 ; 178 (2-3). 161-166 (Pubitemid 40379210)
74. Hinrikus H, Suhhova A, Bachmann M, et al. Electroencephalographic spectral asymmetry index for detection of depression. Med Biol Eng Comput. 2009 ; 47 (12). 1291-1299
75. Hjorth S, Auerbach SB. Further evidence for the importance of 5-HT1A autoreceptors in the action of selective serotonin reuptake inhibitors. Eur J Pharmacol. 1994 ; 260 (2-3). 251-255
76. Holland RL, Wesnes K, Dietrich B. Single dose human pharmacology of umespirone. Eur J Clin Pharmacol. 1994 ; 46: 461-468 (Pubitemid 24199210)
77. Holthoff VA, Beuthien-Baumann B, Zundorf G, et al. Changes in brain metabolism associated with remission in unipolar major depression. Acta Psychiatr Scand. 2004 ; 110 (3). 184-194 (Pubitemid 39120321)
78. Holtzheimer PE, Russo J, Avery DH. A meta-analysis of repetitive transcranial magnetic stimulation in the treatment of depression. Psychopharmacol Bull. 2001 ; 35 (4). 149-169
79. Hsu FC, Garside MJ, Massey AE, McAllister-Williams RH. Effects of a single dose of cortisol on the neural correlates of episodic memory and error processing in healthy volunteers. Psychopharmacology. 2003 ; 167 (4). 431-442 (Pubitemid 36754246)
80. Iosifescu DV, Greenwald S, Devlin P, et al. Frontal EEG predictors of treatment outcome in major depressive disorder. Eur Neuropsychopharmacol. 2009 ; 19 (11). 772-777
81. Ising M, Horstmann S, Kloiber S, et al. Combined dexamethasone/ corticotropin releasing hormone test predicts treatment response in major depression - a potential biomarker?. Biol Psychiatry. 2007 ; 62 (1). 47-54 (Pubitemid 46898222)
82. John ER, Prichep LS. The relevance of QEEG to the evaluation of behavioral disorders and pharmacological interventions. Clin EEG Neurosci. 2006 ; 37 (2). 135-143 (Pubitemid 43726204)
83. John ER, Prichep LS, Fridman J, Easton P. Neurometrics: computer-assisted differential diagnosis of brain dysfunctions. Science. 1988 ; 239 (4836). 162-169 (Pubitemid 18026016)
84. Jones NA, Field T, Fox NA, Lundy B, Davalos M. EEG activation in 1-month-old infants of depressed mothers. Dev Psychopathol. 1997 ; 9 (3). 491-505 (Pubitemid 127439081)
85. Juckel G, Hegerl U, Molnar M, Csepe V, Karmos G. Auditory evoked potentials reflect serotonergic neuronal activity - a study in behaving cats administered drugs acting on 5-HT1A autoreceptors in the dorsal raphe nucleus. Neuropsychopharmacology. 1999 ; 21 (6). 710-716
86. Juckel G, Pogarell O, Augustin H, et al. Differential prediction of first clinical response to serotonergic and noradrenergic antidepressants using the loudness dependence of auditory evoked potentials in patients with major depressive disorder. J Clin Psychiatry. 2007 ; 68 (8). 1206-1212 (Pubitemid 47395622)
87. Kawasaki T, Tanaka S, Wang J, Hokama H, Hiramatsu K. Abnormalities of P300 cortical current density in unmedicated depressed patients revealed by LORETA analysis of event-related potentials. Psychiatry Clin Neurosci. 2004 ; 58 (1). 68-75 (Pubitemid 38200374)
88. Kentgen L, Tenke C, Pine D, Fong R, Klein R, Bruder G. Electroencephalographic asymmetries in adolescents with major depression: influence of comorbidity with anxiety disorders. J Abnorm Psychol. 2000 ; 109 (4). 797-802 (Pubitemid 32096243)
89. Killgore WD, Gruber SA, Yurgelun-Todd DA. Depressed mood and lateralized prefrontal activity during a Stroop task in adolescent children. Neurosci Lett. 2007 ; 416 (1). 43-48 (Pubitemid 46428017)
90. Kimbrell TA, Little JT, Dunn RT, et al. Frequency dependence of antidepressant response to left prefrontal repetitive transcranial magnetic stimulation (rTMS) as a function of baseline cerebral glucose metabolism. Biol Psychiatry. 1999 ; 46 (12). 1603-1613 (Pubitemid 30001602)
91. Kirsch I, Deacon BJ, Huedo-Medina TB, Scoboria A, Moore TJ, Johnson BT. Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration. PLoS Med. 2008 ; 5 (2). e45-e45
92. Klimesch W. EEG alpha and theta oscillations reflect cognitive and memory performance: a review and analysis. Brain Res Brain Res Rev. 1999 ; 29 (2-3). 169-195 (Pubitemid 29191338)
93. Knott VJ. Quantitative EEG methods and measures in human psychopharmacological research. Hum Psychopharmacol. 2000 ; 15 (7). 479-498
94. Knott VJ, Telner JI, Lapierre YD, Browne M, Horn ER. Quantitative EEG in the prediction of antidepressant response to imipramine. J Affect Disord. 1996 ; 39 (3). 175-184 (Pubitemid 26291783)
95. Knyazev GG. Motivation, emotion, and their inhibitory control mirrored in brain oscillations. Neurosci Biobehav Rev. 2007 ; 31 (3). 377-395 (Pubitemid 46241452)
96. Koles ZJ. Trends in EEG source localization. Electroencephalogr Clin Neurophysiol. 1998 ; 106 (2). 127-137 (Pubitemid 28133392)
97. Korb AS, Cook IA, Hunter AM, Leuchter AF. Brain electrical source differences between depressed subjects and healthy controls. Brain Topogr. 2008 ; 21 (2). 138-146
98. Korb AS, Hunter AM, Cook IA, Leuchter AF. Rostral anterior cingulate cortex theta current density and response to antidepressants and placebo in major depression. Clin Neurophysiol. 2009 ; 120 (7). 1313-1319
99. Korostenskaja M, Kahkonen S. What do ERPs and ERFs reveal about the effect of antipsychotic treatment on cognition in schizophrenia?. Curr Pharm Des. 2009 ; 15 (22). 2573-2593
100. Kubicki S, Herrmann WM. The future of computer-assisted investigation of the polysomnogram: sleep microstructure. J Clin Neurophysiol. 1996 ; 13 (4). 285-294 (Pubitemid 26269771)
101. Kuo CC and Tsai JF (2010) Cordance or Antidepressant Treatment Response (ATR) index? Psychiatry Res 180(1): 60.
102. Kwon JS, Youn T, Jung HY. Right hemisphere abnormalities in major depression: quantitative electroencephalographic findings before and after treatment. J Affect Disord. 1996 ; 40 (3). 169-173 (Pubitemid 26338515)
103. Laufs H, Kleinschmidt A, Beyerle A, et al. EEG-correlated fMRI of human alpha activity. Neuroimage. 2003 ; 19 (4). 1463-1476 (Pubitemid 37025845)
104. Lee TW, Yu YW, Chen TJ, Tsai SJ. Loudness dependence of the auditory evoked potential and response to antidepressants in Chinese patients with major depression. J Psychiatry Neurosci. 2005 ; 30 (3). 202-205 (Pubitemid 40942459)
105. Leuchter AF, Cook IA, Lufkin RB, et al. Cordance: a new method for assessment of cerebral perfusion and metabolism using quantitative electroencephalography. Neuroimage. 1994 ; 1 (3). 208-219 (Pubitemid 24253436)
106. Leuchter AF, Uijtdehaage SH, Cook IA, O'Hara R, Mandelkern M. Relationship between brain electrical activity and cortical perfusion in normal subjects. Psychiatry Res. 1999 ; 90 (2). 125-140 (Pubitemid 29256142)
107. Leuchter AF, Cook IA, Witte EA, Morgan M, Abrams M. Changes in brain function of depressed subjects during treatment with placebo. Am J Psychiatry. 2002 ; 159 (1). 122-129 (Pubitemid 41070737)
108. Leuchter AF, Cook IA, Marangell LB, et al. Comparative effectiveness of biomarkers and clinical indicators for predicting outcomes of SSRI treatment in Major Depressive Disorder: results of the BRITE-MD study. Psychiatry Res. 2009 ; 169 (2). 124-131
109. Linka T, Muller BW, Bender S, Sartory G. The intensity dependence of the auditory evoked N1 component as a predictor of response to Citalopram treatment in patients with major depression. Neurosci Lett. 2004 ; 367 (3). 375-378 (Pubitemid 39178616)
110. Linka T, Muller BW, Bender S, Sartory G, Gastpar M. The intensity dependence of auditory evoked ERP components predicts responsiveness to reboxetine treatment in major depression. Pharmacopsychiatry. 2005 ; 38 (3). 139-143 (Pubitemid 40965968)
111. Linka T, Sartory G, Bender S, Gastpar M, Muller BW. The intensity dependence of auditory ERP components in unmedicated patients with major depression and healthy controls. An analysis of group differences. J Affect Disord. 2007 ; 103 (1-3). 139-145 (Pubitemid 47445765)
112. Marrosu F, Fornal CA, Metzler CW, Jacobs BL. 5-HT1A agonists induce hippocampal theta activity in freely moving cats: role of presynaptic 5-HT1A receptors. Brain Res. 1996 ; 739 (1-2). 192-200 (Pubitemid 26387377)
113. Massey AE, Marsh VR, McAllister-Williams RH. Lack of effect of tryptophan depletion on the loudness dependency of auditory event related potentials in healthy volunteers. Biol Psychol. 2004 ; 65 (2). 137-145 (Pubitemid 38050148)
114. Mayberg HS. Limbic-cortical dysregulation: a proposed model of depression. f Neuropsychiatry Clin Neurosci. 1997 ; 9 (3). 471-481 (Pubitemid 27363950)
115. Mayberg HS, Liotti M, Brannan SK, et al. Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness. Am J Psychiatry. 1999 ; 156 (5). 675-682 (Pubitemid 29220063)
116. McAllister-Williams RH. Misinterpretation of randomized trial evidence: do antidepressants work?. Br J Hosp Med (Lond). 2008 ; 69 (5). 246-247
117. McAllister-Williams RH, Massey AE. EEG effects of buspirone and pindolol: a method of examining 5-HT(1A) receptor function in humans. Psychopharmacology. 2003 ; 166 (3). 284-293 (Pubitemid 36384776)
118. McAllister-Williams RH, Rugg MD. Effects of repeated cortisol administration on brain potential correlates of episodic memory retrieval. Psychopharmacology. 2002 ; 160 (1). 74-83
119. McAllister-Williams RH, Marsh VR and Massey AE (2004) Increased sensitivity of somatodendritic 5-HT1A autorecptors in depression. J Psychopharm 18(3 Suppl): A17.
120. McAllister-Williams RH, Massey AE, Fairchild G. Repeated cortisol administration attenuates the EEG response to buspirone in healthy volunteers: evidence for desensitization of the 5-HT1A autoreceptor. J Psychopharmacol. 2007 ; 21 (8). 826-832 (Pubitemid 350029191)
121. McAllister-Williams RH, Hanson A, Alhaj HA, Marsh VR, Massey AE and Pariante CM (2009) Citalopram modulation of the effects of cortisol on cortical activity in healthy male subjects. Biol Psychiatry 65(8S): 238S.
122. Michel CM, Murray MM, Lantz G, Gonzalez S, Spinelli L, Grave DP. EEG source imaging. Clin Neurophysiol. 2004 ; 115 (10). 2195-2222 (Pubitemid 39200787)
123. Miller JM, Oquendo MA, Ogden RT, Mann JJ and Parsey RV (2008) Serotonin transporter binding as a possible predictor of one-year remission in major depressive disorder. J Psychiatr Res 42(14): 1137-1144.
124. Monk CS, Nelson CA. The effects of hydrocortisone on cognitive and neural function: a behavioral and event-related potential investigation. Neuropsychopharmacology. 2002 ; 26 (4). 505-519 (Pubitemid 34261000)
125. Moore P, Landolt HP, Seifritz E, et al. Clinical and physiological consequences of rapid tryptophan depletion. Neuropsychopharmacology. 2000 ; 23 (6). 601-622
126. Morgan ML, Witte EA, Cook IA, Leuchter AF, Abrams M, Siegman B. Influence of age, gender, health status, and depression on quantitative EEG. Neuropsychobiology. 2005 ; 52 (2). 71-76 (Pubitemid 41160323)
127. Mottaghy FM, Keller CE, Gangitano M, et al. Correlation of cerebral blood flow and treatment effects of repetitive transcranial magnetic stimulation in depressed patients. Psychiatry Res. 2002 ; 115 (1-2). 1-14 (Pubitemid 34880095)
128. Mucci A, Volpe U, Merlotti E, Bucci P, Galderisi S. Pharmaco-EEG in psychiatry. Clin EEG Neurosci. 2006 ; 37 (2). 81-98 (Pubitemid 43726200)
129. Mulert C, Juckel G, Brunnmeier M, et al. Prediction of treatment response in major depression: integration of concepts. J Affect Disord. 2007a ; 98 (3). 215-225 (Pubitemid 46149060)
130. Mulert C, Juckel G, Brunnmeier M, et al. Rostral anterior cingulate cortex activity in the theta band predicts response to antidepressive medication. Clin EEG Neurosci. 2007b ; 38 (2). 78-81 (Pubitemid 46866506)
131. Mulert C, Pogarell O, Juckel G, et al. The neural basis of the P300 potential. Focus on the time-course of the underlying cortical generators. Eur Arch Psychiatry Clinl Neurosci. 2004 ; 254 (3). 190-198 (Pubitemid 39304470)
132. Murasaki M, Miura S, Ishigooka J, Ishii Y, Takahashi A, Fukuyama Y. Phase I study of a new antianxiety drug, buspirone. Prog Neuropsychopharmacol Biol Psychiatry. 1989 ; 13 (1-2). 137-144 (Pubitemid 19120541)
133. Murphy FC, Nimmo-Smith I, Lawrence AD. Functional neuroanatomy of emotions: a meta-analysis. Cogn Affect Behav Neurosci. 2003 ; 3 (3). 207-233 (Pubitemid 38620283)
134. Niedermeyer E, Da Silva FHL Electroencephalography: Basic Principles, Clinical Applications and Related Fields. 2004 ) Electroencephalography: Basic Principles, Clinical Applications and Related Fields5th ed. Philadelphia: Lippincott Williams and Wilkins. Philadelphia: Lippincott Williams and Wilkins ; 2004 :
135. Nitz DA, McNaughton BL. Hippocampal EEG and unit activity responses to modulation of serotonergic median raphe neurons in the freely behaving rat. Learn Mem. 1999 ; 6 (2). 153-167 (Pubitemid 29207264)
136. Nunez PL, Srinivasan R Electric Fields of the Brain: The Neurophysics of EEG. 2006 ) Electric Fields of the Brain: The Neurophysics of EEG2nd ed. New York: Oxford University Press. New York: Oxford University Press ; 2006 :
137. O'Donnell BF, Vohs JL, Hetrick WP, Carroll CA, Shekhar A. Auditory event-related potential abnormalities in bipolar disorder and schizophrenia. Int J Psychophysiol. 2004 ; 53 (1). 45-55 (Pubitemid 38686681)
138. Ollikainen JO, Vauhkonen M, Karjalainen PA, Kaipio JP. Effects of electrode properties on EEG measurements and a related inverse problem. Med Eng Phys. 2000 ; 22 (8). 535-545 (Pubitemid 32157544)
139. O'Neill BV, Croft RJ, Nathan PJ. The loudness dependence of the auditory evoked potential (LDAEP) as an in vivo biomarker of central serotonergic function in humans: rationale, evaluation and review of findings. Hum Psychopharmacol. 2008 ; 23 (5). 355-370
140. Padberg F, Zwanzger P, Thoma H, et al. Repetitive transcranial magnetic stimulation (rTMS) in pharmacotherapy-refractory major depression: comparative study of fast, slow and sham rTMS. Psychiatry Res. 1999 ; 88 (3). 163-171 (Pubitemid 30074173)
141. Paige SR, Fitzpatrick DF, Kline JP, Balogh SE, Hendricks SE. Event-related potential amplitude/intensity slopes predict response to antidepressants. Neuropsychobiology. 1994 ; 30 (4). 197-201 (Pubitemid 24350939)
142. Paige SR, Hendricks SE, Fitzpatrick DF, Balogh S, Burke WJ. Amplitude/intensity functions of auditory event-related potentials predict responsiveness to bupropion in major depressive disorder. Psychopharm Bull. 1995 ; 31 (2). 243-248
143. Pascual-Leone A, Catala MD, Pascual-Leone PA. Lateralized effect of rapid-rate transcranial magnetic stimulation of the prefrontal cortex on mood. Neurology. 1996 ; 46 (2). 499-502 (Pubitemid 26081340)
144. Pascual-Marqui RD, Michel CM, Lehmann D. Low resolution electromagnetic tomography: a new method for localizing electrical activity in the brain. Int J Psychophysiol. 1994 ; 18 (1). 49-65 (Pubitemid 24344515)
145. Perlis RH. Pharmacogenetic studies of antidepressant response: how far from the clinic?. Psychiatr Clin North Am. 2007 ; 30 (1). 125-138 (Pubitemid 46386301)
146. Phillips MA, Oxtoby EK, Langley RW, Bradshaw CM, Szabadi E. Effects of acute tryptophan depletion on prepulse inhibition of the acoustic startle (eyeblink) response and the N1/P2 auditory evoked response in man. J Psychopharm. 2000 ; 14 (3). 258-265
147. Phillips C, Rugg MD, Fristont KJ. Systematic regularization of linear inverse solutions of the EEG source localization problem. Neuroimage. 2002 ; 17 (1). 287-301
148. Picton TW, Bentin S, Berg P, et al. Guidelines for using human event-related potentials to study cognition: recording standards and publication criteria. Psychophysiology. 2000 ; 37 (2). 127-152 (Pubitemid 30140280)
149. Pizzagalli D, Pascual-Marqui RD, Nitschke JB, et al. Anterior cingulate activity as a predictor of degree of treatment response in major depression: evidence from brain electrical tomography analysis. Am J Psychiatry. 2001 ; 158 (3). 405-415 (Pubitemid 32205197)
150. Pizzagalli DA, Oakes TR, Davidson RJ. Coupling of theta activity and
151. Pollock VE, Schneider LS. Quantitative, waking EEG research on depression. Biol Psychiatry. 1990 ; 27 (7). 757-780 (Pubitemid 20132244)
152. Prichep LS, Mas F, Hollander E, et al. Quantitative electroencephalographic subtyping of obsessive-compulsive disorder. Psychiatry Res. 1993 ; 50 (1). 25-32 (Pubitemid 23135269)
153. Pruus K, Skrebuhhova-Malmros T, Rudissaar R, Matto V, Allikmets L. 5-HT1A receptor agonists buspirone and gepirone attenuate apomorphine-induced aggressive behaviour in adult male Wistar rats. J Physiol Pharmacol. 2000 ; 51 (4 Pt 2). 833-846
154. Putnam KM, McSweeney LB. Depressive symptoms and baseline prefrontal EEG alpha activity: a study utilizing Ecological Momentary Assessment. Biol Psychol. 2008 ; 77 (2). 237-240
155. Reid SA, Duke LM, Allen JJ. Resting frontal electroencephalographic asymmetry in depression: inconsistencies suggest the need to identify mediating factors. Psychophysiology. 1998 ; 35 (4). 389-404 (Pubitemid 28275372)
156. Reilly JG, McTavish SF, Young AH. Rapid depletion of plasma tryptophan: a review of studies and experimental methodology. J Psychopharm. 1997 ; 11 (4). 381-392 (Pubitemid 27526048)
157. Rijnders HJ, Slangen JL. The discriminative stimulus properties of buspirone involve dopamine-2 receptor antagonist activity. Psychopharmacology (Berl). 1993 ; (111(1). 55-61 (Pubitemid 23101352)
158. Saito A, Kinoshita T, Okajima Y, Yagyu T, Saito M, Schollnhammer G. Quantitative pharmaco-EEG study of ipsapirone (BAY q 7821) in healthy volunteers. Jap J Neuropharm. 1993 ; 15: 359-373 (Pubitemid 23245645)
159. Saletu B, Grunberger J, Linzmayer L. On central effects of serotonin re-uptake inhibitors: quantitative EEG and psychometric studies with sertraline and zimelidine. J Neural Trans. 1986 ; 67 (3-4). 241-266 (Pubitemid 17184851)
160. Saletu B, Anderer P, Saletu-Zyhlarz GM, Arnold O, Pascual-Marqui RD. Classification and evaluation of the pharmacodynamics of psychotropic drugs by single-lead pharmaco-EEG, EEG mapping and tomography (LORETA). Methods Find Exp Clin Pharmacol. 2002 ; 24 (Suppl. C). 97-120 (Pubitemid 35447388)
161. Sauseng P, Klimesch W, Gruber W, Doppelmayr M, Stadler W, Schabus M. The interplay between theta and alpha oscillations in the human electroencephalogram reflects the transfer of information between memory systems. Neurosci Lett. 2002 ; 324 (2). 121-124 (Pubitemid 34457819)
162. Savitz J, Lucki I, Drevets WC. 5-HT(1A) receptor function in major depressive disorder. Prog Neurobiol. 2009 ; 88 (1). 17-31
163. Saxena S, Brody AL, Ho ML, Zohrabi N, Maidment KM, Baxter LR. Differential brain metabolic predictors of response to paroxetine in obsessive-compulsive disorder versus major depression. Am J Psychiatry. 2003 ; 160 (3). 522-532 (Pubitemid 41094261)
164. Scherg M, Von Cramon D. Evoked dipole source potentials of the human auditory cortex. Electroencephalogr Clin Neurophysiol. 1986 ; 65 (5). 344-360 (Pubitemid 16048434)
165. Schmidt LA, Fox NA, Goldberg MC, Smith CC, Schulkin J. Effects of acute prednisone administration on memory, attention and emotion in healthy human adults. Psychoneuroendocrinology. 1999 ; 24 (4). 461-483 (Pubitemid 29204806)
166. Serretti A, Artioli P, Quartesan R. Pharmacogenetics in the treatment of depression: pharmacodynamic studies. Pharmacogenet Genomics. 2005 ; 15 (2). 61-67 (Pubitemid 40562982)
167. Siegle GJ, Condray R, Thase ME, Keshavan M, Steinhauer SR. Sustained gamma-band EEG following negative words in depression and schizophrenia. Int J Psychophysiol. 2010 ; 75 (2). 107-118
168. Siepmann M, Krause S, Joraschky P, Muck-Weymann M, Kirch W. The effects of St John's wort extract on heart rate variability, cognitive function and quantitative EEG: a comparison with amitriptyline and placebo in healthy men. Br J Clin Pharmacol. 2002 ; 54 (3). 277-282
169. Smit DJ, Posthuma D, Boomsma DI, Geus EJ. Heritability of background EEG across the power spectrum. Psychophysiology. 2005 ; 42 (6). 691-697 (Pubitemid 43943072)
170. Smith GS, Reynolds III CF, Pollock B, et al. Cerebral glucose metabolic response to combined total sleep deprivation and antidepressant treatment in geriatric depression. Am J Psychiatry. 1999 ; 156 (5). 683-689 (Pubitemid 29220064)
171. Souza VB, Muir WJ, Walker MT, et al. Auditory P300 event-related potentials and neuropsychological performance in schizophrenia and bipolar affective disorder. Biol Psychiatry. 1995 ; 37 (5). 300-310
172. Sternbach HA, Extein I, Sweeney DR, Gold MS, Pottash AL. Cortisol secretion and urinary MHPG in unipolar depression. Int J Psychiatry Med. 1983 ; 13 (4). 261-266 (Pubitemid 14143290)
173. Stubbeman WF, Leuchter AF, Cook IA, et al. Pretreatment neurophysiologic function and ECT response in depression. J ECT. 2004 ; 20 (3). 142-144 (Pubitemid 39281563)
174. Suffin SC, Emory WH. Neurometric subgroups in attentional and affective disorders and their association with pharmacotherapeutic outcome. Clin Electroencephalogr. 1995 ; 26 (2). 76-83
175. Thibodeau R, Jorgensen RS, Kim S. Depression, anxiety, and resting frontal EEG asymmetry: a meta-analytic review. J Abnorm Psychol. 2006 ; 115 (4). 715-729 (Pubitemid 44747800)
176. Tops M, Wijers AA, van Staveren AS, et al. Acute cortisol administration modulates EEG alpha asymmetry in volunteers: relevance to depression. Biol Psychol. 2005 ; 69 (2). 181-193 (Pubitemid 40445399)
177. Towers DN, Allen JJ. A better estimate of the internal consistency reliability of frontal EEG asymmetry scores. Psychophysiology. 2009 ; 46 (1). 132-142
178. Ulrich G, Frick K. A new quantitative approach to the assessment of stages of vigilance as defined by spatiotemporal EEG patterning. Percept Mot Skills. 1986 ; 62 (2). 567-576
179. Ulrich G, Renfordt E, Zeller G, Frick K. Interrelation between changes in the EEG and psychopathology under pharmacotherapy for endogenous depression. A contribution to the predictor question. Pharmacopsychiatry. 1984 ; 17 (6). 178-183 (Pubitemid 15213945)
180. Ulrich G, Haug HJ, Stieglitz RD, Fahndrich E. Are there distinct biochemical subtypes of depression? EEG characteristics of clinically defined on-drug responders and non-responders. J Affect Disord. 1988 ; 15 (2). 181-185
181. Valle M, Barbanoj MJ, Jane F. Pharmaco-electroencephalography and pharmacokinetic/pharmacodynamic modeling in basic research: focus on human pharmacology. Methods Find Exp Clin Pharmacol. 2002 ; 24 (Suppl. D). 129-137 (Pubitemid 35462377)
182. Van der Stelt O, Belger A. Application of electroencephalography to the study of cognitive and brain functions in schizophrenia. Schizophr Bull. 2007 ; 33 (4). 955-970 (Pubitemid 47216646)
183. Vertes RP. Brain stem generation of the hippocampal EEG. Prog Neurobiol. 1982 ; 19 (3). 159-186
184. Vertes RP, Kinney GG, Kocsis B, Fortin WJ. Pharmacological suppression of the median raphe nucleus with serotonin1A agonists, 8-OH-DPAT and buspirone, produces hippocampal theta rhythm in the rat. Neuroscience. 1994 ; 60 (2). 441-451
185. Volpe U, Mucci A, Bucci P, Merlotti E, Galderisi S, Maj M. The cortical generators of P3a and P3b: a LORETA study. Brain Res Bull. 2007 ; 73 (4-6). 220-230 (Pubitemid 46880056)
186. Wager TD, Phan KL, Liberzon I, Taylor SF. Valence, gender, and lateralization of functional brain anatomy in emotion: a meta-analysis of findings from neuroimaging. Neuroimage. 2003 ; 19 (3). 513-531 (Pubitemid 36926274)
187. Wisniewski GS, McAllister-Williams RH, Jakitowicz J, Nowicki Z, Majkowicz M, Trzebiatowska IA. Effects of antidepressant drugs on electroencephalography alpha power: importance of study duration. Biol Psychiatry. 2008 ; 64 (10). e5-e6
188. Wrobel A. Beta activity: a carrier for visual attention. Acta Neurobiol Exp (Wars). 2000 ; 60 (2). 247-260 (Pubitemid 30353783)
189. Wu J, Buchsbaum MS, Gillin JC, et al. Prediction of antidepressant effects of sleep deprivation by metabolic rates in the ventral anterior cingulate and medial prefrontal cortex. Am J Psychiatry. 1999 ; 156 (8). 1149-1158 (Pubitemid 29374872)
190. Yao D. A method to standardize a reference of scalp EEG recordings to a point at infinity. Physiol Measur. 2001 ; 22 (4). 693-711 (Pubitemid 33104656)
191. Zyss T. May depression be a form of epilepsy? Some remarks on the bioelectric nature of depression. Med Hypotheses. 2009 ; 73 (5). 746-752